信雅達(600571.SH)擬向阿里投資1810.15萬元轉讓諧雲科技7.45%股權
格隆匯12月10日丨信雅達(600571.SH)公佈,公司擬合計以1810.1484萬元將公司持有的諧雲科技7.4492%股權(對應諧雲科技的註冊資本150萬元人民幣)轉讓給杭州阿里巴巴創業投資管理有限公司(以下簡稱“阿里投資”)。
公司投資諧雲科技的原始投資成本為人民幣500萬元,本次轉讓完成後,公司將不再持有諧雲科技的股權,公司將從本次轉讓中獲得股權轉讓收入人民幣1810.1484萬元(未扣除交易產生的相關税費);本次交易有利於公司鎖定投資利潤,不會損害公司及全體股東的利益,不會對公司的財務、經營造成不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.